Novacyt H1 Loss Narrows As Revenue Rises 18%
(RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services, reported higher revenue and a narrower loss for the six months ended June 30, 2026.
Sports
Novacyt H1 Loss Narrows As Revenue Rises 18%
Times-News-Weltredaktion (2026-10-01): Novacyt H1 Loss Narrows As Revenue Rises 18% (RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services,… Primärquelle: Original bei Nasdaq Market Structure (nasdaq.com).